Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters

Schizophrenia Bulletin

Volumn 24, Issue 2, 1998, Pages 267-283

  O'Donnell, Patricio ^b   Grace, Anthony A ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dopamine; Hippocampus; Negative symptoms; Nucleus accumbens; Positive symptoms; Prefrontal cortex; Thalamus; Thought disorder

Indexed keywords

DOPAMINE;

COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; HUMAN; NEUROPATHOLOGY; NEUROPSYCHOLOGY; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; THALAMUS; THINKING;

EID: 0031752320     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033325     Document Type: Review

References (151)

1. Agnati, L.F.; Zoli, M.; Strömberg, I.; and Fuxe, K. Intercellular communication in the brain: Wiring versus volume transmission. Neuroscience, 69:711-726, 1995.
2. Akil, M., and Lewis, D.A. Reduced dopamine innervation of the prefrontal cortex in schizophrenia. [Abstract] Society for Neuroscience Abstracts, 22:1679, 1996.
3. Alexander, G.E.; DeLong, M.R.; and Strick, P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9:357-381, 1986.
4. Altschuler, L.L.; Conrad, A.; Kovelman, J.A.; and Scheibel, A. Hippocampal pyramidal cell orientation in schizophrenia. Archives of General Psychiatry, 44:1094-1098, 1987.
5. Andreasen, N.C.; Arndt, S.; Swayze, V.; Cizadlo, T.; Flaum, M.; O'Leary, D.S.; Ehrhardt, J.C.; and Yuh, W.T.C. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science, 266:294-298, 1994a.
6. Andreasen, N.C.; Flashman, L.; Flaum, M.; Arndt, S.; Swayze, V.; O'Leary, D.S.; Ehrhardt, J.C.; and Yuh, W.T.C. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. Journal of the American Medical Association, 272:1763-1769, 1994b.
7. Angrist, B.; Peselow, E.; Rubinstein, M.; Corwin, J.; and Rotrosen, J. Partial improvement in negative schizophrenia symptoms after amphetamine. Psychopharmacology, 78:128-130, 1982.
8. Angrist, B.; Rotrosen, J.; and Gershon, S. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology, 72:17-19, 1980.
9. Angrist, B.; Santhananthan, G.; Wilk, S.; and Gershon, S. Amphetamine psychosis: Behavioral and biochemical aspects. Journal of Psychiatric Research, 11:13-23, 1974.
10. Angrist, B.; Shopin, B.; and Gershon, S. Comparative psychotomimetic effects of stereoisomers of amphetamine. Nature, 234:152-153, 1971.
11. Arnold, S.E.; Hyman, B.T.; Van Hoesen, G.W.; and Damasio, A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry, 48:625-632, 1991.
12. Bardgett, M.E.; Jackson, J.L.; Taylor, G.T.; and Csernansky, J.G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: An animal model of schizophrenia. Behavioral Brain Research, 70:153-164, 1995.
13. Barta, P.E.; Pearlson, G.D.; Powers, R.E.; Richards, S.S.; and Tune, L.E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. American Journal of Psychiatry, 147:1457-1462, 1990.
14. Batista, J.F.; Galiano, M.C.; Torres, L.A.; Hernandez, M.C.; Sosa, F.; Perera, A.; and Pérez, M. Brain single-photon emission tomography with technetium-99m hexamethylpropylene amine oxime in adolescents with initial-stage schizophrenia. European Journal of Nuclear Medicine, 22:1274-1277, 1995.
15. Benes, F.M.; Davidson, J.; and Bird, E.D. Quantitative cytoarchitectural studies of cerebral cortex of schizophrenics. Archives of General Psychiatry, 43:31-35, 1986.
16. A receptor binding in superficial layers of cingulate cortex in schizophrenics. Journal of Neuroscience, 12:924-929, 1992.
17. Berman, K.F.; Zee, R.F.; and Weinberger, D.R. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: II. Role of neuroleptic treatment, attention, and mental effort. Archives of General Psychiatry, 43:126-135, 1986.
18. Beuger, M.; van Kammen, D.P.; Kelley, M.E.; and Yao, J. Dopamine turnover in schizophrenia before and after haloperidol withdrawal: CSF, plasma, and urine studies. Neuropsychopharmacology, 15:75-86, 1996.
19. Bogerts, B.; Lieberman, J.A.; Ashtari, M.; Bilder, R.M.; Degreef, G.; Lerner, G.; Johns, C.; and Masiar, S. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biological Psychiatry, 33:236-246, 1993.
20. Bogerts, B.; Meertz, E.; and Schönfeldt-Bausch, R. Basal ganglia and limbic system pathology in schizophrenia. Archives of General Psychiatry, 42:784-791, 1985.
21. Bredt, D.S., and Snyder, S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proceedings of the National Academy of Sciences of the United States of America, 86:9030-9033, 1989.
22. Buchanan, R.W.; Strauss, M.E.; Kirkpatrick, B.; Holstein, C.; Breier, A.; and Carpenter, W.T., Jr. Neuropsychological impairments in deficit vs. nondeficit forms of schizophrenia. Archives of General Psychiatry, 51:804-811, 1994.
23. Buchsbaum, M.S. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin, 16(3):379-389, 1990.
24. Buckley, P.F.; Moore, C.; Long, H.; Larkin, C.; Thompson, P.; Mulvany, F.; Redmond, O.; Stack, J.P.; Ennis, J.T.; and Waddington, J.L. 1 H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates. Biological Psychiatry, 36(12):792-800, 1994.
25. Bunney, B.S., and Grace, A.A. Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sciences, 23:1715-1728, 1978.
26. Busatto, G.F.; David, A.S.; Costa, D.C.; Ell, P.J.; Pilowsky, L.S.; Lucey, J.V.; and Kerwin, R.W. Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography. Psychiatry Research, 61:255-264, 1995.
27. Carlsson, A., and Lindqvist, M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacologica et Toxicologica, 20:140-144, 1963.
28. Carlsson, M., and Carlsson, A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trends in Neuroscience, 13:272-276, 1990.
29. Chao, L.L., and Knight, R.T. Human prefrontal lesions increase distractibility to irrelevant sensory inputs. Neuroreport, 6:1605-1610, 1995.
30. Chapman, L.J.; Chapman, J.P.; and Miller, G.A. A theory on verbal behavior in schizophrenia. In: Maher, B., ed. Progress in Experimental Personality Research. Vol. I. New York, NY: Academic Press, 1964. pp. 49-77.
31. Chen, J.; Paredes, W.; and Gardner, E.L. Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: Further evidence for depolarization block. Neuroscience Letters, 122:127-131, 1991.
32. Chiodo, L.A., and Bunney, B.S. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. Journal of Neuroscience, 3:1607-1619, 1983.
33. Christison, G.W.; Casanova, M.F.; Weinberger, D.R.; and Rawlings, R. A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Archives of General Psychiatry, 46:1027-1032, 1989.
34. Conrad, A.J.; Abebe, T.; Austin, R.; Forsythe, S.; and Scheibel, A.B. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of General Psychiatry, 48(5):413-417, 1991.
35. Conrad, A.J., and Scheibel, A.B. Schizophrenia and the hippocampus: The embryological hypothesis extended. Schizophrenia Bulletin, 13(4):577-587, 1987.
36. Creese, I.; Burt, D.R.; and Snyder, S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 192:596-598, 1976.
37. Daviss, S.R., and Lewis, D.A. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Research, 59:81-96, 1995.
38. de Silva, W.P., and Hemsley, D.R. The influence of context on language perception in schizophrenia. British Journal of Social and Clinical Psychology, 16:337-345, 1977.
39. Deutch, A.Y.; Lee, M.C.; and Iadarola, M.J. Regionally specific effects of atypical antipsychotic drugs on striatal fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Molecular and Cellular Neuroscience, 3:332-341, 1992.
40. East, S.J., and Garthwaite, J. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neuroscience Letters, 123:17-19, 1991.
41. Falkai, P., and Bogerts, B. Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatric and Neurological Sciences, 236:154-161, 1986.
42. Falkai, P.; Bogerts, B.; Schneider, T.; Greve, B.; Pfeiffer, U.; Pilz, K.; Gonsiorzcyk, C.; Majtenyi, C.; and Ovary, I. Disturbed planum temporale asymmetry in schizophrenia: A quantitative postmortem study. Schizophrenia Research, 14:161-176, 1995.
43. Feasey-Truger, K.J.; Earl, C.D.; Alzheimer, C.; and ten Bruggencate, G. Stimulus-evoked dopamine overflow in the rat nucleus accumbens is decreased following chronic haloperidol administration: An in vivo voltammetric study. Neuroscience Letters, 183:91-95, 1995.
44. Feinberg, l. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research, 17:319-334, 1982.
45. Fey, E.T. The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test. Journal of Consulting Psychology, 15:311-319, 1951.
46. Friston, K.J. The dorsolateral prefrontal cortex, schizophrenia, and PET. Journal of Neural Transmission, 37:79-93, 1992.
47. Goldberg, T.E.; Bigelow, L.B.; Weinberger, D.R.; Daniel, D.G.; and Kleinman, J.E. Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. American Journal of Psychiatry, 148:78-84, 1991.
48. Goldberg, T.E.; Weinberger, D.R.; Berman, K.F.; Pliskin, N.H.; and Podd, M.H. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Archives of General Psychiatry, 44:1008-1014, 1987.
49. Grace, A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41:1-24, 1991.
50. Grace, A.A. The depolarization block hypothesis of neuroleptic action: Implications for the etiology and treatment of schizophrenia. Journal of Neural Transmission, 36:91-131, 1992.
51. Grace, A.A.; Bunney, B.S.; Moore, H.; and Todd, C.L. Dopamine cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends in Neuroscience, 20(1):31-37, 1997.
52. Grace, A.A., and Moore, H. Gap junction inactivation in the striatum prevents oral stereotypy induced by apomorphine. (Abstract] Society for Neuroscience Abstracts, 22:405, 1996.
53. Gur, R.E., and Pearlson, G.D. Neuroimaging in schizophrenia research. Schizophrenia Bulletin, 19(2):337-353, 1993.
54. Hagiwara, S., and Monta, H. Electrotonic transmission between two nerve cells in leech ganglion. Journal of Neurophysiology, 25:721-727, 1962.
55. Harden, D.G., and Grace, A.A. Hippocampal activation suppresses VTA dopamine cell firing: A potential role for hippocampal regulation of phasic DA release. [Abstract] Society for Neuroscience Abstracts, 21:1660, 1995.
56. Harvey, I.; Ron, M.A.; Du Boulay, G.; Wicks, D.; Lewis, S.W.; and Murray, R.M. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychological Medicine, 23:591-604, 1993.
57. 1 receptor activation. Journal of Physiology, 492:143-154, 1996.
58. Henry, D.J.; Wise, R.A.; Rompré, P.-R; and White, F.J. Acute depolarization block of A10 dopamine neurons: Interactions of morphine with dopamine antagonists. Brain Research, 596:231-237, 1992.
59. Heritch, A.J. Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. Schizophrenia Bulletin, 16(4):605-615, 1990.
60. Hernandez, L., and Hoebel, B.C. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Brain Research Bulletin, 22:763-769, 1989.
61. Honer, W.G.; Bassett, A.S.; Falkai, P.; Beach, T.G.; and Lapointe, J.S. A case study of temporal lobe development in familial schizophrenia. Psychological Medicine, 26:191-195, 1996.
62. Honey, C.R.; Miljovic, Z.; and MacDonald, J.F. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neuroscience Letters, 61:135-139, 1985.
63. Jarrard, L.E. What does the hippocampus really do? Behavioral Brain Research, 71:1-10, 1995.
64. Javitt, D.C., and Zukin, S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry, 148:1301-1308, 1991.
65. Jenkins, R.B., and Groh, R.H. Mental symptoms in parkinsonian patients treated with L-dopa. Lancet, II: 177-179, 1970.
66. Johansson, O., and Hökfelt, T. Nucleus accumbens: Transmitter histochemistry with special reference to peptide-containing neurons. In: Chronister, R.B., and DeFrance, J.F., eds. The Neurobiology of the Nucleus Accumbens. Brunswick, ME: Hauer Institute, 1981. pp. 147-171.
67. Kahn, R.S.; Harvey, P.D.; Davidson, M.; Keefe, R.S.E.; Apter, S.; Neale, J.M.; Mohs, R.C.; and Davis, R.L. Neuropsychological correlates of central monoamine function in chronic schizophrenia: Relationship between CSF metabolites and cognitive function. Schizophrenia Research, 11:217-224, 1994.
68. Kawasaki, Y.; Maeda, Y.; Suzuki, M.; Urata, K.; Higashima, M.; Kiba, K.; Yamaguchi, N.; Matsuda, H.; and Hisada, K. SPECT analysis of regional cerebral blood flow changes in patients with schizophrenia during the Wisconsin Card Sorting Test. Schizophrenia Research, 10:109-116, 1993a.
69. Kawasaki, Y.; Maeda, Y.; Urata, K.; Higashima, M.; Yamaguchi, N.; Suzuki, M.; Takashima, T.; and Ide, Y. A quantitative magnetic resonance imaging study of patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 242:268-272, 1993b.
70. Kawasaki, Y.; Suzuki, M.; Maeda, Y.; Urata, K.; Yamaguchi, N.; Matsuda, H.; Hisada, K.; and Takashima, T. Regional cerebral blood flow in patients with schizophrenia: A preliminary report. European Archives of Psychiatry and Clinical Neuroscience, 241:195-200, 1992.
71. Kerwin, R.; Patel, S.; and Meldrum, B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience, 39:25-32, 1990.
72. 2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. Biological Psychiatry, 36:827-835, 1994.
73. Kovelman, J.A., and Scheibel, A.B. A neurohistological correlate of schizophrenia. Biological Psychiatry, 19:1601-1917, 1984.
74. Lane, R.F., and Blaha, C.D. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: Depolarization block as a possible mechanism of action. Brain Research Bulletin, 18:135-138, 1987.
75. Lavín, A., and Grace, A.A. The modulation of mediodorsal and dorsal thalamic nuclei by the ventral pallidum: Its role in the regulation of thalamocortical activity in the basal ganglia. Synapse, 18:104-127, 1994.
76. Levine, M.S.; Li, Z.; Cepeda, C.; Cromwell, H.C.; and Altemus, K.L. Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices. Synapse, 24:65-78, 1996.
77. Liddle, P.F.; Friston, K.J.; Frith, C.D.; and Frackowiak, R.S.J. Cerebral blood flow and mental processes in schizophrenia. Journal of the Royal Society of Medicine, 85:224-227, 1992a.
78. Liddle, P.F.; Friston, K.J.; Frith, C.D.; Hirsch, S.R.; Jones, T.; and Frackowiak, R.S.J. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry, 160:179-186, 1992b.
79. Lipska, B.K.; Jaskiw, G.E.; Chrapusta, S.; Karoum, F.; and Weinberger, D.R. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Research, 585:1-6, 1992.
80. Lozsádi, D.A. Organization of cortical afférents to the rostral, limbic sector of the rat thalamic reticular nucleus. Journal of Comparative Neurology, 341:520-533, 1994.
81. Luby, E.D.; Cohen, B.D.; Rosenbaum, G.; Gottlieb, J.S.; and Kelly, R. Study of a new schizophreniamimetic drug - Sernyl. Archives of Neurology and Psychiatry, 81:363-369, 1959.
82. Luby, E.D.; Gottlieb, J.S.; Cohen, B.D.; Rosenbaum, G.; and Domino, E.F. Model psychoses and schizophrenia. American Journal of Psychiatry, 119:61-67, 1962.
83. Marsh, L.; Suddath, R.L.; Higgins, N.; and Weinberger, D.R. Medial temporal lobe structures in schizophrenia: Relationship of size to duration of illness. Schizophrenia Research, 11:225-238, 1994.
84. 76Br-Bromolisuride. British Journal of Psychiatry, 158:346-350, 1991.
85. Matthysse, S. Antipsychotic drug actions: A clue to the neuropathology of schizophrenia? Federation Proceedings, 32:200-205, 1973.
86. Mogenson, G.J.; Jones, D.L.; and Yim, C.Y. From motivation to action: Functional interface between limbic system and the motor system. Progress in Neurobiology, 14:69-97, 1980.
87. Nasrallah, H.A.; Fowler, R.C.; and Judd, L.L. Schizophrenia-like illness following head injury. Psychosomatics, 22:359-361, 1981.
88. 1H MRS) of the hippocampal formation in schizophrenia: A pilot study. British Journal of Psychiatry, 165:481-485, 1994.
89. 1like dopamine receptors. Journal of Neuroscience, 16:1591-1604, 1996.
90. O'Donnell, P., and Grace, A.A. Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens. Journal of Neuroscience, 13:3456-3471, 1993a.
91. O'Donnell, P., and Grace, A.A. Physiological and morphological properties of accumbens core and shell neurons recorded in vitro. Synapse, 13:135-160, 1993b.
92. 2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Research, 634:105-112, 1994.
93. O'Donnell, P., and Grace, A.A. Different effects of subchronic clozapine and haloperidol on dye coupling between neurons in the rat striatal complex. Neuroscience, 66:763-767, 1995a.
94. O'Donnell, P., and Grace, A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: Hippocampal gating of prefrontal cortical input. Journal of Neuroscience, 15:3622-3639, 1995b.
95. O'Donnell, P., and Grace, A.A. Dopaminergic reduction of excitability in nucleus accumbens neurons recorded in vitro. Neuropsychopharmacology, 15:87-98, 1996.
96. O'Donnell, P., and Grace, A.A. Cortical afferents modulate striatal gap junction permeability via nitric oxide. Neuroscience, 76:1-5, 1997.
97. O'Donnell, P.; Lavín, A.; Enquist, L.W.; Grace, A.A.; and Card, J.P. Interconnected parallel circuits between rat nucleus accumbens and thalamus revealed by retrograde transynaptic transport of pseudorabies virus. Journal of Neuroscience, 17:2143-2167, 1997.
98. Olney, J.W., and Farber, N.B. Glutamate receptor dysfunction and schizophrenia. Archives of General Psychiatry, 52:998-1007, 1995.
99. Ong, W.Y., and Garey, L.J. Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia. Schizophrenia Research, 10:15-27, 1993.
100. Onn, S.-P., and Grace, A.A. Dye coupling between rat striatal neurons recorded in vivo: Compartmental organization and modulation by dopamine. Journal of Neurophysiology, 71:1917-1934, 1994.
101. Onn, S.-P., and Grace, A.A. Repeated treatment with haloperidol and clozapine exerts differential effects on dye coupling between neurons in subregions of striatum and nucleus accumbens. Journal of Neuroscience, 15:7024-7036, 1995.
102. Owen, F.; Cross, A.J.; Crow, T.J.; Lofthouse, R.; and Poulter, M. Neurotransmitter receptors in brain in schizophrenia. Acta Psychiatrica Scandinavica, 291(Suppl.):20-26, 1981.
103. Pakkenberg, B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Archives of General Psychiatry, 47:1023-1028, 1990.
104. Pakkenberg, B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophrenia Research, 7:95-100, 1992.
105. Pakkenberg, B. Leucotomized schizophrenics lose neurons in the mediodorsal thalamic nucleus. Neuropathology and Applied Neurobiology, 19:373-380, 1993.
106. Parellada, E.; Catafau, A.M.; Bemardo, M.; Lomena, F.; González-Monclús, E.; and Setoain, J. Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study. Psychiatry Research, 55:131-139, 1994.
107. Parent, A., and Hazrati, L.-N. Functional anatomy of the basal ganglia: I. The cortico-basal ganglia-thalamo-cortical loop. Brain Research Reviews, 20:91-127, 1995.
108. Patterson, T.A., and Schenk, J.O. Effects of acute and chronic systemic administration of some typical antipsychotic drugs on turnover of dopamine and potassium-induced release of dopamine in the striatum of the rat in vivo. Neuropharmacology, 30:943-952, 1991.
109. 1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens. Journal of Neurophysiology, 67:1325-1334, 1992.
110. Perry, R.G.; Barta, P.E.; Pearlson, G.D.; McGilchrist, I.K.; Lewis, R.W.; Tien, A.Y.; Pulver, A.; Vaughn, D.D.; Casanova, M.F.; and Powers, R.E. Reversal of asymmetry of the planum temporale in schizophrenia. American Journal of Psychiatry, 152:715-721, 1995.
111. Pettegrew, J.W.; Keshavan, M.; Panchalingham, K.; Strychor, S.; Kaplan, D.B.; Tretta, M.G.; and Allen, M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Archives of General Psychiatry, 48:563-568, 1991.
112. Popli, A., and Jaskiw, G.E. L-Dopa for schizophrenia: High time for reconsideration. [Abstract] Schizophrenia Research, 15:162, 1995.
113. Post, R.M.; Fink, E.; Carpenter, W.T., Jr.; and Goodwin, F.K. Cerebrospinal fluid amine metabolites in acute schizophrenia. Archives of General Psychiatry, 32:1063-1069, 1975.
114. Rao, M.L., and Möller, H.-J. Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment. Pharmacopsychiatry, 30:160-172, 1994.
115. Ribeyre, J.-M.; Lesieur, P.; Varoquaux, O.; Dollfus, S.; Pays, M.; and Petit, M. A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia. Biological Psychiatry, 36:230-236, 1994.
116. Rosenbaum, G.; Cohen, B.D.; Luby, J.S.; Gottlieb, J.S.; and Yelen, D. Comparison of sernyl with other drugs: Stimulation of schizophrenia performance with sernyl, LSD-25, and amylbarbitol (amytal) sodium. Archives of General Psychiatry, 1:113-118, 1959.
117. Rossi, A.; Stratta, P.; Mancini, F.; Galluci, M.; Mattel, P.; Core, L.; Di Michele, V.; and Casacchia, M. Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinkage in male patients with schizophrenia. Psychiatry Research, 52:43-53, 1994.
118. Sanfilipo, M.; Wolkin, A.; Angrist, B.; van Kammen, D.P.; Duncan, E.; Wieland, S.; Cooper, T.B.; Peselow, E.D.; and Rotrosen, J. Amphetamine and negative symptoms of schizophrenia. Psychopharmacology, 123:211-214, 1996.
119. 1-dopamine receptor in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. Journal of Neurophysiology, 71:515-528, 1994.
120. Schultz, W. Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. Journal of Neurophysiology, 56:1439-1461, 1986.
121. Schultz, W. Behavior-related activity of primate dopamine neurons. Revue Neurologique, 150:634-639, 1994.
122. Seeman, P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse, 1:133-152, 1987.
123. Selemon, L.D.; Rajkowska, G.; and Goldman-Rakic, P.S. Abnormally high neuronal density in the schizophrenic cortex. Archives of General Psychiatry, 52:805-818, 1995.
124. Shenton, M.E.; Kikinis, R.; Jolesz, F.A.; Pollak, S.D.; LeMay, M.; Wible, C.G.; Hokama, H.; Martin, J.; Metcalf, D.; Coleman, M.; and McCarley, R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. New England Journal of Medicine, 327:604-612, 1992.
125. Shiori, T.; Kalo, T.; Inubushi, T.; Murashita, J.; and Takahashi, S. Correlations of phosphomonoesters measured by phosphorous-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Research, 55:223-235, 1994.
126. 3H] antagonist dopamine receptor binding. Experientia, 38:1224-1225, 1982.
127. Silbersweig, D.A.; Stern, E.; Frith, C.; Cahill, C.; Holmes, A.; Grootoonk, S.; Seaward, J.; McKenna, P.; Chua, S.E.; Schnorr, L.; Jones, T.; and Frackowiak, R.S.J. A functional neuroanatomy of hallucinations in schizophrenia. Nature, 378:176-179, 1995.
128. Skarsfeldt, T. Differential effects after repeated treatment with haloperidol, clozapine, thioridazine, and tefludazine on SNC and VTA dopamine neurones in rats. Life Sciences, 42:1037-1044, 1988.
129. Skarsfeldt, T. Comparison of short-term administration of sertindole, clozapine, and haloperidol on the inactivation of midbrain dopamine neurons in the rat. European Journal of Pharmacology, 254:291-294, 1994.
130. Snyder, S.H. Catecholamines in the brain as mediators of amphetamine psychosis. Archives of General Psychiatry, 27:169-179, 1972.
131. Spitzer, M. The psychopathology, neuropsychology, and neurobiology of associative and working memory in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 243:57-70, 1993.
132. Steriade, M., and Llinás, R.R. The functional states of the thalamus and the associated neuronal interplay. Physiological Reviews, 68:649-742, 1988.
133. Suddath, R.L.; Christison, G.W.; Torrey, E.F.; Casanova, M.F.; and Weinberger, D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 322:789-794, 1990.
134. 123I-IMP SPECT. European Archives of Psychiatry and Clinical Neuroscience, 242:257-261, 1993.
135. Swanson, L.W. A direct projection from Ammon's horn to prefrontal cortex in the rat. Brain Research, 217:150-154, 1981.
136. Tamminga, C.A.; Thaker, G.K.; Buchanan, R.; Kirkpatrick, B.; Alphs, L.D.; Chase, T.N.; and Carpenter, W.T., Jr. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry, 49:522-530, 1992.
137. Todorova, A., and Dimpfel, W. Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs. European Neuropsychopharmacology, 4:491-501, 1994.
138. Turetsky, B.; Cowell, P.E.; Gur, R.C.; Grossman, R.I.; Shtasel, D.L.; and Gur, R.E. Frontal and temporal lobe brain volumes in schizophrenia. Archives of General Psychiatry, 52:1061-1070, 1995.
139. Ułas, J., and Cotman, C.W. Excitatory amino acid receptors in schizophrenia. Schizophrenia Bulletin, 19(1): 105-117, 1993.
140. Uylings, H.B.M. and van Eden, C.G. Qualitative and quantitative comparison of the profrontal cortex in rat and in primates, including humans. Progress in Brain Research, 85:31-62, 1990.
141. van Kammen, D.P.; van Kammen, W.B.; Mann, L.S.; Seppala, T.; and Linnoila, M. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Archives of General Psychiatry, 43:978-983, 1986.
142. Weinberger, D.R.; Berman, K.F.; and Illowsky, B. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism. Archives of General Psychiatry, 45:609-615, 1988.
143. Weinberger, D.R.; Berman, K.F.; Suddath, R.; and Torrey, E.F. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. American Journal of Psychiatry, 149:890-897, 1992.
144. White, F.J., and Wang, R.Y. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science, 221:1054-1057, 1983.
145. Wible, C.G.; Shenton, M.E.; Hokama, H.; Kikinis, R.; Jolesz, F.; Metcalf, D.; and McCarley, R.W. Prefrontal cortex and schizophrenia. Archives of General Psychiatry, 52:279-288, 1995.
146. Wilson, C.J., and Kawaguchi, Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. Journal of Neuroscience, 16:2397-2410, 1996.
147. Wolkin, A.; Sanfilipo, M.; Wolf, A.P.; Angrist, B.; Brodie, J.D.; and Rotrosen, J. Negative symptoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry, 49:959-965, 1992.
148. Yang, C.R., and Mogenson, G.J. Electrophysiological responses of neurones in the accumbens nucleus to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system. Brain Research, 324:69-84, 1984.
149. Yurgelun-Todd, D.A.; Renshaw, P.F.; Gruber, S.A.; Ed, M.; Waternaux, C.; and Cohen, B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophrenia Research, 19:55-59, 1996a.
150. Yurgelun-Todd, D.A.; Waternaux, C.M.; Cohen, B.M.; Gruber, S.A.; English, C.D.; and Renshaw, P.P. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. American Journal of Psychiatry, 153:200-205, 1996b.
151. Zahm, D.S.; Williams, E.; and Wohltmann, C. Ventral striatopallidothalamic projection: IV. Relative involvements of neurochemically distinct subterritories in the ventral pallidum and adjacent parts of the rostroventral forebrain. Journal of Comparative Neurology, 364:340-362, 1996.